Post-earnings recap
Reported
Thu, May 13, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp's earnings report indicates a significant miss on EPS, which contributed to a sharp decline in stock price by 13.4%. The lack of guidance and management's defensive tone suggest uncertainties in the market that could impact future performance. Investors may need to consider these factors as they evaluate the company's outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.46 | N/A | -30.83% |
Overall, management expressed concern over current market conditions impacting profitability. They did not provide specific guidance for future quarters.
Management acknowledged challenges in meeting earnings expectations.
They highlighted ongoing market pressures affecting performance.